The past month has been pretty extraordinary. But there are signs that the market is starting to act more rationally and waiting on new data to see whether valuations are oversold, or need to be ratcheted down some more.
The major focus is again on the shocks in the labor market with two new reports. Today’s initial jobless claims rose to 6.648 million, nearly doubling expectations for a new record high of 3.5 million.
The coronavirus pandemic, which has caused a nationwide shutdown of the economy, forcing school closures and and bring business production to a screeching halt, is unprecedented. It’s unlike anything we’ve ever seen.
On Monday, I wrote that while stocks could be expected to hold onto most of the gains seen last week early in this week, the month’s, and therefore the quarter’s, end yesterday could prove to be a short-term turning point.
In a recent exclusive interview for our Nasdaq Amplify newsletter, Nasdaq's Karen Snow spoke with Betsy Atkins to discuss emerging governance trends in the boardroom including term limits, ESG and evolving activism behavior.
Nasdaq surveyed activity for five of the largest actively managed small-cap funds. We’ve recapped the activity and highlighted key trends and rotations to provide clarity on how these funds are being positioned in this Amplify exclusive.
For many investors, tapping factors via exchange traded funds is the way to go, but many value ETFs use antiquated approaches that may exacerbate the factor's current struggles.
Yesterday, stock in Johnson and Johnson (JNJ) surged eight percent after the company reported that it would begin clinical trials on humans for its Covid-19 vaccine, with an eye to it being available for general use early next year.